aspirin has been researched along with Hyperplasia in 58 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "compared with aspirin monotherapy, the combination of aspirin plus clopidogrel did not significantly reduce the process of SVG intimal hyperplasia 1 year after coronary artery bypass grafting." | 9.14 | Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. ( Delarochelliere, R; Kulik, A; Le May, MR; Mesana, TG; Naidoo, S; Ruel, M; Tardif, JC; Voisine, P; Wells, GA, 2010) |
| "We sought to evaluate the impact of cilostazol on neointimal hyperplasia after drug-eluting stent (DES) implantation in patients with diabetes mellitus (DM)." | 9.13 | Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Im ( Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC, 2008) |
| "To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women." | 9.12 | Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. ( Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H, 2007) |
| "This study was designed to investigate the efficacy of cilostazol on the prevention of in-stent neointimal hyperplasia as measured by both quantitative coronary angiography (CAG) and volumetric intravascular ultrasound (IVUS)." | 9.12 | Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study. ( Choi, D; Jang, Y; Jung, JH; Ko, YG; Min, PK; Shim, WH, 2007) |
| "Paclitaxel-eluting stents used with conventional antiplatelet therapy effectively inhibit restenosis and neointimal hyperplasia, with a safety profile similar to that of standard stents." | 9.10 | A paclitaxel-eluting stent for the prevention of coronary restenosis. ( Choi, D; Ho, DS; Hong, MK; Jang, Y; Lam, R; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Raizner, AE; Shim, WH; Weissman, NJ, 2003) |
| " This study aimed to investigate the effects of aspirin on non-specific inflammation developing into cancer." | 8.12 | Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation. ( Chen, Y; Diao, T; Li, D; Shang, G; Shi, L; Sun, L; Yin, X, 2022) |
| "Data were compared between asthmatic patients who reported exacerbations after aspirin ingestion and those who did not." | 7.73 | Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. ( Borish, L; Hunt, J; Mascia, K; Patrie, J; Phillips, CD; Steinke, JW, 2005) |
| "Previous studies have shown that agents such as indomethacin and hydrocortisone act to reduce the level of epidermal hyperplasia produced by various chemical, but little information is available about the effects of such anti-inflammatory agents on the induction of hyperplasia in oral mucosa." | 7.67 | Effects of the anti-inflammatory agents indomethacin, metiamide and acetylsalicylic acid on the induction of hyperplasia in hamster cheek-pouch epithelium and ear epidermis. ( Harris, RR; Mackenzie, IC, 1984) |
| "This experiment evaluated the effect of aspirin (ASA) on the patency and development of intimal hyperplasia in autologous, small caliber, arterial end-to-side anastomosis." | 7.67 | Patency and intimal hyperplasia: the effect of aspirin on small arterial anastomosis. ( Henderson, T; Moore, WS; Quiñones-Baldrich, WJ; Ziomek, S, 1988) |
| "The combination of aspirin and dipyridamole is currently used to prevent intimal hyperplasia and to improve long-term vein graft patency following myocardial revascularization." | 7.67 | Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. ( Cameron, C; Landymore, RW; MacAulay, M; Sheridan, B, 1986) |
| "Aspirin has anti-inflammatory and antineoplastic activity." | 5.35 | Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. ( Chan, AO; Chen, MH; Cho, CH; Gu, Q; Hu, PJ; Li, GQ; Liang, YJ; Lin, HL; Qiao, L; So, WH; Tatematsu, M; Tsukamoto, T; Wong, BC; Xia, HH; Yuen, MF, 2008) |
| "However, systemic study of thrombus formation in vein grafts is still lacking, and few effective techniques are available to prevent this event." | 5.32 | Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. ( Hu, Y; Mayr, U; Thompson, WD; Torsney, E; Xu, Q; Zou, Y, 2004) |
| "The aspirin was started before operation and continued for 6 weeks after operation, at which time the endarterectomized vessels were excised." | 5.27 | Early healing after carotid endarterectomy: effect of high- and low-dose aspirin on thrombosis and early neointimal hyperplasia in a nonhuman primate model. ( Bush, HL; Jakubowski, JA; Sentissi, JM, 1988) |
| "compared with aspirin monotherapy, the combination of aspirin plus clopidogrel did not significantly reduce the process of SVG intimal hyperplasia 1 year after coronary artery bypass grafting." | 5.14 | Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. ( Delarochelliere, R; Kulik, A; Le May, MR; Mesana, TG; Naidoo, S; Ruel, M; Tardif, JC; Voisine, P; Wells, GA, 2010) |
| "We sought to evaluate the impact of cilostazol on neointimal hyperplasia after drug-eluting stent (DES) implantation in patients with diabetes mellitus (DM)." | 5.13 | Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Im ( Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC, 2008) |
| "To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women." | 5.12 | Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. ( Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H, 2007) |
| "This study was designed to investigate the efficacy of cilostazol on the prevention of in-stent neointimal hyperplasia as measured by both quantitative coronary angiography (CAG) and volumetric intravascular ultrasound (IVUS)." | 5.12 | Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study. ( Choi, D; Jang, Y; Jung, JH; Ko, YG; Min, PK; Shim, WH, 2007) |
| "Paclitaxel-eluting stents used with conventional antiplatelet therapy effectively inhibit restenosis and neointimal hyperplasia, with a safety profile similar to that of standard stents." | 5.10 | A paclitaxel-eluting stent for the prevention of coronary restenosis. ( Choi, D; Ho, DS; Hong, MK; Jang, Y; Lam, R; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Raizner, AE; Shim, WH; Weissman, NJ, 2003) |
| " This study aimed to investigate the effects of aspirin on non-specific inflammation developing into cancer." | 4.12 | Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation. ( Chen, Y; Diao, T; Li, D; Shang, G; Shi, L; Sun, L; Yin, X, 2022) |
| "Reducing the dose of sirolimus eluting from a biocompatible HAp coated stent reduces signs of delayed vascular healing, without affecting neointimal hyperplasia." | 3.75 | Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing. ( Peters-Krabbendam, I; Serruys, PW; Sorop, O; van Beusekom, HM; van der Giessen, WJ, 2009) |
| "Data were compared between asthmatic patients who reported exacerbations after aspirin ingestion and those who did not." | 3.73 | Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. ( Borish, L; Hunt, J; Mascia, K; Patrie, J; Phillips, CD; Steinke, JW, 2005) |
| "Aspirin is frequently used after vascular reconstruction to pharmacologically prevent graft occlusion and to suppress the development of myointimal hyperplasia in vascular surgery, but its efficacy is controversial." | 3.69 | Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation. ( Bredenberg, CE; Couper, L; Harvey, R; Himmelfarb, J, 1997) |
| "At 4 weeks, the degree of intimal hyperplasia of the graft of E5510 group was significantly less than that of the Aspirin group and the Control group (p < 0." | 3.69 | The inhibition of canine vein graft intimal thickening using a newly developed antiplatelet agent. ( Eguchi, D; Itoh, H; Kawasaki, K; Komori, K; Kuma, S; Mawatari, K; Okazaki, J; Onohara, T; Sugimachi, K, 1997) |
| "The purpose of this study was to evaluate the efficacy of three drugs (cilazapril, cyclosporine, and aspirin) in modulating the progression of intimal hyperplasia during short postoperative times in short-segment, autogenous vein bypass grafts in a canine model." | 3.68 | Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts. ( Evancho, MM; Hirko, MK; McShannic, JR; Schmidt, SP; Sharp, WV; Siebert, JD; Sims, RL, 1993) |
| "Previous studies have shown that agents such as indomethacin and hydrocortisone act to reduce the level of epidermal hyperplasia produced by various chemical, but little information is available about the effects of such anti-inflammatory agents on the induction of hyperplasia in oral mucosa." | 3.67 | Effects of the anti-inflammatory agents indomethacin, metiamide and acetylsalicylic acid on the induction of hyperplasia in hamster cheek-pouch epithelium and ear epidermis. ( Harris, RR; Mackenzie, IC, 1984) |
| "The combination of aspirin and dipyridamole is currently used to prevent intimal hyperplasia and to improve long-term vein graft patency following myocardial revascularization." | 3.67 | Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. ( Cameron, C; Landymore, RW; MacAulay, M; Sheridan, B, 1986) |
| "The effect of aspirin, reserpine, and flurbiprofen on in vivo platelet function and intimal smooth muscle cell hyperplasia in rat carotid arteries subjected to endothelial injury was investigated and related to the effect of these drugs on in vitro platelet aggregation." | 3.65 | Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. ( Clowes, AW; Karnovsky, MJ, 1977) |
| "Aspirin was administered daily for 1 month prior and 4 months following aortic injury." | 2.38 | The effect of prolonged aspirin therapy on experimental balloon-catheter arterial wall injury. ( Connell, RS; Galey, WT; Jacobson, S; Shoemake, RG; Trune, DR; Vetto, RM; Yeager, RA, 1990) |
| "Aspirin has anti-inflammatory and antineoplastic activity." | 1.35 | Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. ( Chan, AO; Chen, MH; Cho, CH; Gu, Q; Hu, PJ; Li, GQ; Liang, YJ; Lin, HL; Qiao, L; So, WH; Tatematsu, M; Tsukamoto, T; Wong, BC; Xia, HH; Yuen, MF, 2008) |
| "However, systemic study of thrombus formation in vein grafts is still lacking, and few effective techniques are available to prevent this event." | 1.32 | Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. ( Hu, Y; Mayr, U; Thompson, WD; Torsney, E; Xu, Q; Zou, Y, 2004) |
| "The aspirin was started before operation and continued for 6 weeks after operation, at which time the endarterectomized vessels were excised." | 1.27 | Early healing after carotid endarterectomy: effect of high- and low-dose aspirin on thrombosis and early neointimal hyperplasia in a nonhuman primate model. ( Bush, HL; Jakubowski, JA; Sentissi, JM, 1988) |
| "Aspirin treatment (3, 20, or 40 min) resulted in alterations in tight junction complex morphology and permeability." | 1.27 | Effects of aspirin on tight junction structure of the canine gastric mucosa. ( McGinley, D; Meyer, RA; Posalaky, Z, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (34.48) | 18.7374 |
| 1990's | 11 (18.97) | 18.2507 |
| 2000's | 15 (25.86) | 29.6817 |
| 2010's | 9 (15.52) | 24.3611 |
| 2020's | 3 (5.17) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, Y | 1 |
| Kihara, Y | 1 |
| Okada, M | 1 |
| Inoue, Y | 1 |
| Tochizawa, S | 1 |
| Toga, K | 1 |
| Tachibana, K | 1 |
| Kimura, Y | 1 |
| Nishi, T | 1 |
| Hidaka, H | 1 |
| Chen, Y | 1 |
| Sun, L | 1 |
| Li, D | 1 |
| Yin, X | 1 |
| Shang, G | 1 |
| Diao, T | 1 |
| Shi, L | 1 |
| Guida, GA | 1 |
| Angelini, GD | 1 |
| Ho, JP | 1 |
| Galex, IA | 1 |
| Sadeghi, NB | 1 |
| Weledji, N | 1 |
| Cabello Bermudez, SI | 1 |
| Mitchell, BA | 1 |
| Bush, DM | 1 |
| Yap, E | 1 |
| Davis, NC | 1 |
| Catalino, MP | 1 |
| Godfrey, V | 1 |
| Nielsen, JN | 1 |
| Lee, YZ | 1 |
| Sasaki-Adams, DM | 1 |
| Antigüedad-Muñoz, J | 1 |
| de la Riva, P | 1 |
| Arenaza Choperena, G | 1 |
| Muñoz Lopetegi, A | 1 |
| Andrés Marín, N | 1 |
| Fernández-Eulate, G | 1 |
| Moreno Valladares, M | 1 |
| Martínez Zabaleta, M | 1 |
| Lee, CH | 1 |
| Yu, CY | 1 |
| Chang, SH | 1 |
| Hung, KC | 1 |
| Liu, SJ | 1 |
| Wang, CJ | 1 |
| Hsu, MY | 1 |
| Hsieh, IC | 1 |
| Chen, WJ | 1 |
| Ko, YS | 1 |
| Wen, MS | 1 |
| Petri, MH | 1 |
| Laguna-Fernandez, A | 1 |
| Tseng, CN | 1 |
| Hedin, U | 1 |
| Perretti, M | 1 |
| Bäck, M | 1 |
| Costa, F | 2 |
| Vranckx, P | 2 |
| Leonardi, S | 2 |
| Moscarella, E | 1 |
| Ando, G | 1 |
| Calabro, P | 1 |
| Oreto, G | 1 |
| Zijlstra, F | 1 |
| Valgimigli, M | 3 |
| Gargiulo, G | 2 |
| Ariotti, S | 2 |
| Biscaglia, S | 1 |
| Campo, G | 1 |
| Esposito, G | 1 |
| Windecker, S | 2 |
| Franzone, A | 1 |
| Piccolo, R | 1 |
| Marino, M | 1 |
| Santucci, A | 1 |
| Baldo, A | 1 |
| Magnani, G | 1 |
| Moschovitis, A | 1 |
| Hemetsberger, R | 1 |
| Farhan, S | 1 |
| Strehblow, C | 1 |
| Sperker, W | 1 |
| Pavo, I | 1 |
| Petrasi, Z | 1 |
| Hemetsberger, H | 1 |
| Posa, A | 1 |
| Huber, K | 1 |
| Glogar, D | 1 |
| Gyöngyösi, M | 1 |
| van der Giessen, WJ | 3 |
| Sorop, O | 1 |
| Serruys, PW | 3 |
| Peters-Krabbendam, I | 1 |
| van Beusekom, HM | 2 |
| Weale, AR | 1 |
| Cooper, DG | 1 |
| Kulik, A | 1 |
| Le May, MR | 1 |
| Voisine, P | 1 |
| Tardif, JC | 1 |
| Delarochelliere, R | 1 |
| Naidoo, S | 1 |
| Wells, GA | 1 |
| Mesana, TG | 1 |
| Ruel, M | 1 |
| Gasparovic, H | 1 |
| Petricevic, M | 1 |
| Biocina, B | 1 |
| Bisdas, T | 1 |
| Haverich, A | 1 |
| Teebken, OE | 1 |
| Park, SJ | 2 |
| Shim, WH | 2 |
| Ho, DS | 1 |
| Raizner, AE | 1 |
| Park, SW | 2 |
| Hong, MK | 2 |
| Lee, CW | 2 |
| Choi, D | 2 |
| Jang, Y | 2 |
| Lam, R | 1 |
| Weissman, NJ | 1 |
| Mintz, GS | 1 |
| Torsney, E | 1 |
| Mayr, U | 1 |
| Zou, Y | 1 |
| Thompson, WD | 1 |
| Hu, Y | 1 |
| Xu, Q | 1 |
| Wijns, W | 1 |
| Sianos, G | 1 |
| de Scheerder, I | 1 |
| van den Heuvel, PA | 1 |
| Rutsch, W | 1 |
| Glogar, HD | 1 |
| Macaya, C | 1 |
| Materne, PH | 1 |
| Veldhof, S | 1 |
| Vonhausen, H | 1 |
| Otto-Terlouw, PC | 1 |
| Melero, JM | 1 |
| Porras, C | 1 |
| Such, M | 1 |
| Olalla, E | 1 |
| Alonso, J | 1 |
| Mascia, K | 1 |
| Borish, L | 1 |
| Patrie, J | 1 |
| Hunt, J | 1 |
| Phillips, CD | 1 |
| Steinke, JW | 1 |
| Finn, AV | 1 |
| Joner, M | 1 |
| Nakazawa, G | 1 |
| Kolodgie, F | 1 |
| Newell, J | 1 |
| John, MC | 1 |
| Gold, HK | 1 |
| Virmani, R | 1 |
| Ushijima, K | 1 |
| Yahata, H | 1 |
| Yoshikawa, H | 1 |
| Konishi, I | 1 |
| Yasugi, T | 1 |
| Saito, T | 2 |
| Nakanishi, T | 1 |
| Sasaki, H | 1 |
| Saji, F | 1 |
| Iwasaka, T | 1 |
| Hatae, M | 1 |
| Kodama, S | 1 |
| Terakawa, N | 1 |
| Yaegashi, N | 1 |
| Hiura, M | 1 |
| Sakamoto, A | 1 |
| Tsuda, H | 1 |
| Fukunaga, M | 1 |
| Kamura, T | 1 |
| Min, PK | 1 |
| Jung, JH | 1 |
| Ko, YG | 1 |
| Zou, RJ | 1 |
| Zou, LJ | 1 |
| Huang, SD | 1 |
| Wang, Y | 1 |
| Han, L | 1 |
| Ji, GY | 1 |
| Xu, ZY | 1 |
| Li, GQ | 1 |
| Xia, HH | 1 |
| Chen, MH | 1 |
| Tsukamoto, T | 1 |
| Tatematsu, M | 1 |
| Gu, Q | 1 |
| Qiao, L | 1 |
| Cho, CH | 1 |
| So, WH | 1 |
| Yuen, MF | 1 |
| Hu, PJ | 1 |
| Liang, YJ | 1 |
| Lin, HL | 1 |
| Chan, AO | 1 |
| Wong, BC | 1 |
| Lee, SW | 1 |
| Kim, YH | 1 |
| Yun, SC | 1 |
| Park, DW | 1 |
| Kim, HS | 1 |
| Ko, JK | 1 |
| Park, JH | 1 |
| Lee, JH | 1 |
| Choi, SW | 1 |
| Seong, IW | 1 |
| Cho, YH | 1 |
| Lee, NH | 1 |
| Kim, JH | 1 |
| Chun, KJ | 1 |
| Harris, RR | 1 |
| Mackenzie, IC | 1 |
| Carlson, RP | 1 |
| Gilman, SC | 1 |
| Hodge, TG | 1 |
| O'Neill-Davis, L | 1 |
| Blazek, EM | 1 |
| Lewis, AJ | 1 |
| Wang, ZG | 2 |
| Hagen, DO | 1 |
| Mikat, EM | 2 |
| Fuchs, JC | 2 |
| McCann, RL | 1 |
| Hagen, PO | 2 |
| Cohen, SM | 1 |
| Zenser, TV | 1 |
| Murasaki, G | 1 |
| Fukushima, S | 1 |
| Mattammal, MB | 1 |
| Rapp, NS | 1 |
| Davis, BB | 1 |
| Hackel, DB | 1 |
| Carson, S | 1 |
| Demling, R | 1 |
| Esquivel, C | 1 |
| Talken, L | 1 |
| Tillman, P | 1 |
| Schilderman, PA | 1 |
| ten Vaarwerk, FJ | 1 |
| Lutgerink, JT | 1 |
| Van der Wurff, A | 1 |
| ten Hoor, F | 1 |
| Kleinjans, JC | 1 |
| Hirko, MK | 1 |
| McShannic, JR | 1 |
| Schmidt, SP | 1 |
| Sharp, WV | 1 |
| Evancho, MM | 1 |
| Sims, RL | 1 |
| Siebert, JD | 1 |
| Hårdhammar, PA | 1 |
| Emanuelsson, HU | 1 |
| Hofma, SH | 1 |
| Albertsson, PA | 1 |
| Verdouw, PD | 1 |
| Boersma, E | 1 |
| Stachura, J | 1 |
| Konturek, JW | 1 |
| Dembinski, A | 1 |
| Domschke, W | 1 |
| Harvey, R | 1 |
| Bredenberg, CE | 1 |
| Couper, L | 1 |
| Himmelfarb, J | 1 |
| Martínez, ME | 1 |
| McPherson, RS | 1 |
| Levin, B | 1 |
| Glober, GA | 1 |
| Mawatari, K | 1 |
| Komori, K | 1 |
| Kuma, S | 1 |
| Okazaki, J | 1 |
| Kawasaki, K | 1 |
| Eguchi, D | 1 |
| Itoh, H | 1 |
| Onohara, T | 1 |
| Sugimachi, K | 1 |
| Samaniego, F | 1 |
| Pati, S | 1 |
| Karp, JE | 1 |
| Prakash, O | 1 |
| Bose, D | 1 |
| Oblath, RW | 1 |
| Buckley, FO | 1 |
| Green, RM | 1 |
| Schwartz, SI | 1 |
| DeWeese, JA | 1 |
| Jones, PM | 1 |
| Weirich, EG | 1 |
| Longauer, JK | 1 |
| Kirkwood, AH | 1 |
| Clowes, AW | 1 |
| Karnovsky, MJ | 1 |
| Graham, LM | 1 |
| Brothers, TE | 1 |
| Vincent, CK | 1 |
| Burkel, WE | 1 |
| Stanley, JC | 1 |
| Landymore, RW | 2 |
| MacAulay, MA | 1 |
| Fris, J | 1 |
| Yeager, RA | 1 |
| Trune, DR | 1 |
| Jacobson, S | 1 |
| Connell, RS | 1 |
| Galey, WT | 1 |
| Shoemake, RG | 1 |
| Vetto, RM | 1 |
| Bush, HL | 2 |
| Jakubowski, JA | 2 |
| Sentissi, JM | 2 |
| Quiñones-Baldrich, WJ | 1 |
| Ziomek, S | 1 |
| Henderson, T | 1 |
| Moore, WS | 1 |
| Meyer, RA | 1 |
| McGinley, D | 1 |
| Posalaky, Z | 1 |
| Curl, GR | 1 |
| Hayes, JA | 1 |
| Deykin, D | 1 |
| Bourassa, MG | 1 |
| Fisher, LD | 1 |
| Campeau, L | 1 |
| Gillespie, MJ | 1 |
| McConney, M | 1 |
| Lespérance, J | 1 |
| Fuster, V | 1 |
| Chesebro, JJ | 1 |
| MacAulay, M | 1 |
| Sheridan, B | 1 |
| Cameron, C | 1 |
| Crean, GP | 1 |
| Riede, UN | 1 |
| Torhorst, J | 1 |
| Rohr, HP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PROlonging Dual Antiplatelet Treatment In Patients With Coronary Artery Disease After Graded Stent-induced Intimal Hyperplasia studY[NCT00611286] | Phase 4 | 1,700 participants (Anticipated) | Interventional | 2006-12-31 | Completed | ||
| Impact of Preoperative FFR on Arterial Bypass Graft Functionality: Towards a New CABG Paradigm[NCT02527044] | 120 participants (Anticipated) | Interventional | 2015-11-30 | Active, not recruiting | |||
| Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?[NCT00228423] | Phase 2 | 113 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| A Prospective Optical Coherence Tomography Study on Completeness of Strut Coverage and Vessel Wall Response at 3-6 and 9 Months Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease[NCT00704145] | Phase 4 | 30 participants (Anticipated) | Interventional | 2007-11-30 | Completed | ||
| Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation[NCT02176265] | 31 participants (Actual) | Interventional | 2014-09-30 | Completed | |||
| Vessel Injury in Relation With Strut Thickness Assessed by OCT (VISTA): A Comparison of Vascular Injury Induced by a Polymer Free Sirolimus and Probucol Eluting Stent and a Biodegradable-polymer Biolimus-eluting Stent[NCT03026465] | Phase 4 | 50 participants (Actual) | Interventional | 2017-02-16 | Completed | ||
| In-Vivo Vascular Response of Sirolimus-,Paclitaxel- and Zotarolimus-Eluting Stents in Long Lesions Requiring Overlapping. A Prospective, Randomized, Controlled Study Using Optical Coherence Tomography[NCT00693030] | Phase 4 | 77 participants (Anticipated) | Interventional | 2006-08-31 | Recruiting | ||
| The Optical Coherence Tomography Drug Eluting Stent Investigation(OCTDESI)[NCT00776204] | 60 participants (Actual) | Interventional | 2008-05-31 | Completed | |||
| Frequency Domain Imaging to Determine Stent Strut Coverage and Duration of Anti-Platelet Treatment After Endeavor Stent Placement[NCT01219894] | 0 participants (Actual) | Observational | 2010-11-30 | Withdrawn (stopped due to Number of patients to meet individual IDE requirements was not obtained.) | |||
| Effect of TCFA on Neointimal Coverage After EXCEL Biodegradable Polymer-coated Sirolimus-eluting Stents Implantation at 9 Months Follow-up: Evaluated by Optical Coherence Tomography and Fractional Flow Reserve[NCT02384837] | 33 participants (Actual) | Observational | 2014-12-31 | Completed | |||
| Optical Frequency Domain Imaging (OFDI) Determined Stent Strut Coverage and Plaque Morphology After RESOLUTE Stent Placement in Non-Insulin Dependent Diabetics Presenting With Acute Coronary Syndrome (ACS)[NCT01794949] | 8 participants (Actual) | Interventional | 2013-09-30 | Completed | |||
| Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma[NCT03463252] | Phase 2/Phase 3 | 224 participants (Anticipated) | Interventional | 2018-04-01 | Recruiting | ||
| Study of the Efficacy and Safety of Cilostazol in the Prevention of Ischemic Vascular Events in Diabetic Patients With Symptomatic Peripheral Artery Disease.[NCT02983214] | Phase 4 | 826 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| Comparison of Platelet Inhibitory Effect With Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction Patients According to CYP2C19 Polymorphism[NCT00915733] | Phase 4 | 80 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [NCT00000489] | Phase 3 | 0 participants | Interventional | 1973-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 4 |
| Placebo | 5 |
(NCT00228423)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| 75mg Clopidogrel | 1 |
| Placebo | 0 |
Postoperative angiogram 12 months post-CABG (NCT00228423)
Timeframe: One year following surgery
| Intervention | percentage (Number) |
|---|---|
| 75mg Clopidogrel | 94.3 |
| Placebo | 93.2 |
IVUS imaging 12 months post-CABG, and the average intimal area in the proximal 40 mm of one vein graft per patient will be assessed (NCT00228423)
Timeframe: One year following surgery
| Intervention | mm (Mean) |
|---|---|
| 75mg Clopidogrel | 4.1 |
| Placebo | 4.5 |
Assessment of vascular healing 6 months after Resolute Integrity placement in non-diabetic patients and patients with non-insulin dependent diabetes presenting with acute coronary syndrome (ACS) using optical frequency domain imaging (OFDI). Vascular healing will be measured by percent covered stents as determined by OFDI. A higher percentage of stent coverage indicates increased endothelial regrowth, which is an essential component for the maintenance of long-term luminal patency. (NCT01794949)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| 85% up to 90% stent coverage | 90% up to 95% stent coverage | 95% or greater percent stent coverage | |
| NIDDM Patients Receiving the Resolute Stent | 0 | 1 | 0 |
| Non-diabetic Patients Receiving the Resolute Stent | 1 | 3 | 1 |
5 reviews available for aspirin and Hyperplasia
| Article | Year |
|---|---|
Pathophysiology and Mechanisms of Saphenous Vein Graft Failure.
Topics: Aspirin; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpla | 2022 |
The effect of prolonged aspirin therapy on experimental balloon-catheter arterial wall injury.
Topics: Animals; Aorta, Abdominal; Aspirin; Catheterization; Hyperplasia; Male; Rabbits | 1990 |
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
Topics: Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; | 1985 |
Aortocoronary artery vein-graft disease: experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dogs; Gra | 1985 |
Etiology of peptic ulcer.
Topics: Anxiety Disorders; Aspirin; Bile Acids and Salts; Blood Group Antigens; Diet; Duodenal Ulcer; Female | 1974 |
10 trials available for aspirin and Hyperplasia
44 other studies available for aspirin and Hyperplasia
| Article | Year |
|---|---|
2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities.
Topics: Animals; Arteriosclerosis; Cilostazol; Hyperplasia; Platelet Aggregation Inhibitors; Quinolines; Qui | 1998 |
Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation.
Topics: Animals; Apoptosis; Aspirin; Azoxymethane; Carcinogenesis; Cell Proliferation; Colitis, Ulcerative; | 2022 |
Rabbit Elastase Aneurysm: Imaging and Histology Correlates for Inflammation and Healing.
Topics: Animals; Aspirin; Carotid Artery Diseases; Carotid Artery, Common; Disease Models, Animal; Disease P | 2021 |
Internal Carotid Artery Web as the Cause of Recurrent Cryptogenic Ischemic Stroke.
Topics: Adult; Aspirin; Atorvastatin; Biopsy; Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases | 2018 |
Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.
Topics: Absorbable Implants; Animals; Aorta, Abdominal; Aspirin; Biocompatible Materials; Calcium-Binding Pr | 2014 |
Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Hyperplasia; Lipoxins; Mice; Mice | 2015 |
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Animals; Aspirin; Cell Proliferation; Clopido | 2008 |
Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Cardiovascular Agents; Clopidogrel; Coated Materia | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular | 2009 |
Letter by Gasparovic et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
Topics: Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Artery Disease; Dr | 2011 |
Letter by Bisdas et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
Topics: Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary | 2011 |
Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Arteries; Disease | 2004 |
Severe stenosis of anastomoses by using the symmetry aortic connector system.
Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Arter | 2004 |
Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Asthma; Case-Control Studies; Chronic Disease; Cohort Studies; Drug Hypersensitivity | 2005 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coro | 2007 |
Effect of external stents on prevention of intimal hyperplasia in a canine vein graft model.
Topics: Animals; Aspirin; Dogs; Femoral Vein; Hyperplasia; Stents; Tunica Intima; Ultrasonography, Doppler, | 2007 |
Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Aspirin; Choristoma; Dinoprostone; Epithelial Cells; G | 2008 |
Effects of the anti-inflammatory agents indomethacin, metiamide and acetylsalicylic acid on the induction of hyperplasia in hamster cheek-pouch epithelium and ear epidermis.
Topics: Animals; Aspirin; Cricetinae; Ear, External; Epidermis; Hyperplasia; Indomethacin; Mesocricetus; Met | 1984 |
Effects of oral aspirin and oxaprozin on the development of lupus-like disease in MRL/1 mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Aspirin; Autoim | 1984 |
[Intimal hyperplasia in aorta adjacent to small diameter Gore-Tex graft in monkey and its reduction by antiplatelet therapy].
Topics: Animals; Aorta; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Hyperplasia; Macaca fascicularis; | 1983 |
Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts.
Topics: Animals; Aspirin; Carotid Arteries; Dipyridamole; Femoral Vein; Haplorhini; Hyperplasia; Iliac Arter | 1980 |
Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Topics: Animals; Aspirin; Biotransformation; Cyclooxygenase Inhibitors; FANFT; Hyperplasia; Male; Neoplasms, | 1981 |
Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyr | 1982 |
Testing and treatment of arterial graft thrombosis.
Topics: Animals; Arteries; Aspirin; Blood Vessel Prosthesis; Constriction, Pathologic; Disease Models, Anima | 1981 |
Induction of oxidative DNA damage and early lesions in rat gastro-intestinal epithelium in relation to prostaglandin H synthase-mediated metabolism of butylated hydroxyanisole.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Aspirin; Biotransformation; Butylated Hydroxyanisole; Cell Div | 1995 |
Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Cilazapril; Cyclosporine; Dogs; Female; | 1993 |
Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.
Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Coronary Angiography; Coronary Thrombosis; Coronar | 1996 |
Growth markers in the human gastric mucosa during adaptation to continued aspirin administration.
Topics: Adaptation, Physiological; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Drug | 1996 |
Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Aorta; Arachidonate 12-Lipoxygenase; Arachidonic Acids; | 1997 |
A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps.
Topics: Adenoma; Aged; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; | 1997 |
The inhibition of canine vein graft intimal thickening using a newly developed antiplatelet agent.
Topics: Animals; Aspirin; Blood Flow Velocity; Bromodeoxyuridine; Cell Division; Dogs; Fatty Acids, Monounsa | 1997 |
Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?
Topics: Amino Acid Motifs; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chlorocebus aethiops; | 2001 |
Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Femoral Artery; Hyperplasia; Platelet | 1978 |
Complete dentures and the associated soft tissues.
Topics: Aspirin; Candidiasis; Cheilitis; Denture, Complete; Diagnosis, Oral; Foreign Bodies; Hyperplasia; Ke | 1977 |
Epidermal antihyperplastic effects of contact antiphlogistics.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Bufexamac; Fluocinolone Acetonide; Guinea Pigs; Hydrocor | 1978 |
Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
Topics: Adenosine Diphosphate; Air; Animals; Aspirin; Blood Coagulation Tests; Blood Platelets; Carotid Arte | 1977 |
The role of an endothelial cell lining in limiting distal anastomotic intimal hyperplasia of 4-mm-I.D. Dacron grafts in a canine model.
Topics: Animals; Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Dogs; Endothelium, Vascular; Hyperplasi | 1991 |
Effect of aspirin on intimal hyperplasia and cholesterol uptake in experimental bypass grafts.
Topics: Animals; Arteriosclerosis; Aspirin; Cell Division; Cholesterol; Dogs; Graft Occlusion, Vascular; Hyp | 1991 |
Early healing after carotid endarterectomy: effect of high- and low-dose aspirin on thrombosis and early neointimal hyperplasia in a nonhuman primate model.
Topics: Animals; Aspirin; Bleeding Time; Blood Platelets; Carotid Arteries; Carotid Artery Thrombosis; Endar | 1988 |
Patency and intimal hyperplasia: the effect of aspirin on small arterial anastomosis.
Topics: Anastomosis, Surgical; Animals; Aspirin; Female; Hyperplasia; Iliac Artery; Platelet Adhesiveness; P | 1988 |
Effects of aspirin on tight junction structure of the canine gastric mucosa.
Topics: Animals; Aspirin; Cardia; Dogs; Female; Freeze Fracturing; Gastric Fundus; Gastric Mucosa; Hyperplas | 1986 |
Neointimal hyperplasia occurring after carotid endarterectomy in a canine model: effect of endothelial cell seeding vs. perioperative aspirin.
Topics: Animals; Aspirin; Carotid Arteries; Dogs; Endarterectomy; Hyperplasia; Models, Cardiovascular; Plate | 1987 |
Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts.
Topics: Animals; Aspirin; Blood Platelets; Cod Liver Oil; Dietary Fats; Dipyridamole; Dogs; Drug Combination | 1986 |
Focal proliferation of the smooth endoplasmic reticulum in the cells of the straight part of the proximal kidney tubule.
Topics: Animals; Aspirin; Cell Aggregation; Cytoplasmic Granules; Endoplasmic Reticulum; Hydrocarbons, Bromi | 1973 |